December 8, 2025BloodOpen Access

Patient reported outcome design, conduct and reporting in australasian leukaemia & lymphoma group (ALLG) cooperative group trials

View Full Paper

Ask AI

Bookmark

Authors

JPJodie Palmer EHEliza A. Hawkes NDNicole Wong Doo

Discussion

Member takes

Implication

Analysis shows improved incorporation of patient-reported outcomes in clinical trials for blood cancers, indicating greater adherence to CONSORT-PRO guidance.

Key Points

Patient-reported outcomes were incorporated into 85% of trials analyzing acute myeloblastic leukaemia and other blood cancers.
The reporting of patient-reported outcomes in randomised clinical trial publications has increased notably, with 9 publications expected from 2019-2025.
Analysis of protocols from the Australasian Leukaemia & Lymphoma Group revealed adherence to statistical approaches for PROs and relevant timepoints.
The ongoing prioritization of patient-reported outcomes in ALLG trials highlights the shift towards enhanced reporting standards.

Cite This Study

Palmer et al. (2025) studied this question.

synapsesocial.com/papers/69362f3a4fa91c937236d3c7 https://doi.org/10.1182/blood-2025-4631

View Full Paper

Ask AI

Bookmark

Implication

Analysis shows improved incorporation of patient-reported outcomes in clinical trials for blood cancers, indicating greater adherence to CONSORT-PRO guidance.

Patient reported outcome design, conduct and reporting in australasian leukaemia & lymphoma group (ALLG) cooperative group trials

Discussion

Member takes

Implication

Key Points

Cite This Study

Patient reported outcome design, conduct and reporting in australasian leukaemia & lymphoma group (ALLG) cooperative group trials

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider